SEARCH

SEARCH BY CITATION

References

  • BACHMANN, K.A. & SULLIVAN, T.J. (1983). Dispositional and pharmacodynamic characteristics of brodifacoum in warfarin-sensitive rats. Pharmacol., 27, 281288.
  • BECHTOLD, H., TRENK, D., JAHNCHEN, E. & MEINERTZ, T. (1983). Plasma vitamin K1–2,3-epoxide as diagnostic and to detect surreptitious ingestion of oral anticoagulant drugs. Lancet, i, 596597.
  • BOROWSKI, M., FURIE, B.C., GOLDSMITH, G.H. & FURIE, B. (1985). Metal and phospholipid binding properties of partially carboxylated human prothrombin variants. J. Biol. Chem., 260, 92589264.
  • BOROWSKI, M., FURIE, B.C. & FURIE, B. (1986). Distribution of γ-carboxyglutamic acid residues in partially carboxylated human prothrombins. J. Biol. Chem., 261, 16241628.
  • BRECKENRIDGE, A.M., CHOLERTON, S., HART, J.A.D., PARK, B.K. & SCOTT, A.K. (1985). A study of the relationship between the pharmacokinetics and pharmacodynamics of the 4-hydroxycoumarin anticoagulants warfarin, difenacoum and brodifacoum in the rabbit. Br. J. Pharmacol., 84, 8191.
  • CHOONARA, I.A., SCOTT, A.K., HAYNES, B.P., CHOLERTON, S., BRECKENRIDGE, A.M. & PARK, B.K. (1985). Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients. Br. J. Clin. Pharmacol., 20, 643648.
  • CHOONARA, I.A., MALIA, R.G., HAYES, B.P., HAY, C.R., CHOLERTON, S., BRECKENRIDGE, A.M., PRESTON, F.E. & PARK, B.K. (1988). The relationship between inhibition of vitamine K1 2,3-epoxide reductase and reduction of clotting factor activity with warfarin. Br. J. Clin. Pharmacol., 25, 17.
  • DRUMMOND, D.C. (1966). Rats resistant to warfarin. New Sci., 30, 771772.
  • FASCO, M.J., PRINCIPE, L.M., WALSH, W.A. & FRIEDMAN, P.A. (1983). Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes. Biochemistry, 22, 56555660.
  • GREAVES, J.H. & AYERS, P. (1967). Heritable resistance to warfarin in rats. Nature, 215, 877878.
  • GREEFF, M.C., MASHILE, O. & MACDOUGALL, L.G. (1987). ‘Super-warfarin’ (bromodialone) poisoning in two children resulting in prolonged anticoagulation. Lancet, ii, 1269.
  • GRINNEL, B.W., WALLS, J.D., MARKS, C., GLASEBROOK, A.L., BERG, D.T., YAN, S.B. & BANG, N.U. (1990). γ-Carboxylated isoforms of recombinant human protein S with different biologic properties. Blood, 76, 25462554.
  • HILDEBRANDT, E.F. & SUTTIE, J.W. (1982). Mechanism of coumarin action: sensitivity of vitamin K metabolizing enzymes of normal and warfarin-resistant rat liver. Biochemistry, 21, 24062411.
  • HUCKLE, K.R., HUTSON, D.H., LOGAN, C.J., MORRISON, B.J. & WARBURTON, P.A. (1989). The fate of the rodenticide flocoumafen in the rat: retention and elimination of a single oral dose. Pestic. Sci., 25, 297312.
  • LECK, J.B. & PARK, B.K. (1981). A comparative study of the effects of warfarin and brodifacoum on the relationship between vitamin K1 metabolism and clotting factor activity in warfarin-susceptible and warfarin-resistant rats. Biochem. Pharmacol., 30, 123128.
  • LIPSKY, J.J. (1988). Review: Antibiotic-associated hypoprothrombinaemia. J. Antimicrob. Chemother., 21, 281300.
  • OLSON, R.E. (1984). The function and metabolism of vitamin K. Annu. Rev. Nutr., 4, 281337.
  • PARK, B.K., CHOONARA, I.A., HAYNES, B.P., BRECKENRIDGE, A.M., MALIA, R.G. & PRESTON, F.E. (1986). Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br. J. Clin. Pharmacol., 21, 289294.
  • SACHS, L. (1984). Angewandte Statistik. Sixth edition. pp. 381426. Berlin: Springer-Verlag.
  • SUTTIE, J.W. (1987). Recent advances in hepatic vitamin K metabolism and function. Hepatology, 7, 367376.
  • THIJSSEN, H.H.W. (1987). Warfarin resistance. Vitamin K epoxide reductase of Scottish resistance genes is not irreversibly blocked by warfarin. Biochem. Pharmacol., 36, 27532757.
  • THIJSSEN, H.H.W. & BAARS, L.G.M. (1987). Hepatic uptake and storage of warfarin. The relation with the target enzyme vitamin K2,3-epoxide reductase. J. Pharmacol. Exp. Ther., 243, 10821088.
  • THIJSSEN, H.H.W. & BAARS, L.G.M. (1989). Microsomal warfarin binding and vitamin K 2,3-epoxide reductase. Biochem. Pharmacol., 38, 11151120.
  • THIJSSEN, H.H.W., BAARS, L.G.M. & VERVOORT-PETERS, H.T.M. (1988). Vitamin K 2,3-epoxide reductase: the basis for stereoselectivity of 4-hydroxycoumarin anticoagulant activity. Br. J. Pharmacol., 95, 675682.
  • WEITZEL, J.N., SADOWSKI, J.A., FURIE, B.C., MOROOSE, R., KIM, H., MOUNT, M.E., MURPHY, M.J. & FURIE, B. (1990). Surreptitious ingestion of a long-acting vitamin K antagonist/rodenticide, brodifacoum: clinical and metabolic studies of three cases. Blood, 76, 25552559.
  • ZIMMERMAN, A. & MATSCHINER, J.T. (1974). Biochemical basis of hereditary resistance to warfarin in the rat. Biochem. Pharmacol., 23, 10331040.